Next Quarterly Earnings
Tuesday, November 3, 2026
Expected
Dynavax Technologies is a leading US biotechnology company dedicated to developing and commercializing innovative vaccines and immunotherapies. Through its proprietary adjuvant technology, exemplified by HEPLISAV-B for Hepatitis B, the company provides protection against serious infectious diseases and improves global public health.
Dynavax Technologies last reported quarterly earnings on 11/4/2025 (Q3 2025).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.